Koninklijke Philips N.V. (PHG)
USD 24.71
(-1.2%)
USD 24.71
(-1.2%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 7.61 Billion EUR | -7.17% |
| 2022 | 8.2 Billion EUR | 17.51% |
| 2021 | 6.97 Billion EUR | 0.65% |
| 2020 | 6.93 Billion EUR | 27.3% |
| 2019 | 5.44 Billion EUR | 12.98% |
| 2018 | 4.82 Billion EUR | 2.23% |
| 2017 | 4.71 Billion EUR | -15.88% |
| 2016 | 5.6 Billion EUR | -2.67% |
| 2015 | 5.76 Billion EUR | 40.35% |
| 2014 | 4.1 Billion EUR | 5.2% |
| 2013 | 3.9 Billion EUR | -13.96% |
| 2012 | 4.53 Billion EUR | 17.46% |
| 2011 | 3.86 Billion EUR | -17.13% |
| 2010 | 4.65 Billion EUR | 9.16% |
| 2009 | 4.26 Billion EUR | 1.89% |
| 2008 | 4.18 Billion EUR | 17.56% |
| 2007 | 3.56 Billion EUR | -7.92% |
| 2006 | 3.86 Billion EUR | -13.71% |
| 2005 | 4.48 Billion EUR | -0.6% |
| 2004 | 4.51 Billion EUR | -23.11% |
| 2003 | 5.86 Billion EUR | -17.57% |
| 2002 | 7.11 Billion EUR | -9.69% |
| 2001 | 7.87 Billion EUR | 95.11% |
| 2000 | 4.03 Billion EUR | 21.52% |
| 1999 | 3.32 Billion EUR | -6.83% |
| 1998 | 3.56 Billion EUR | -16.29% |
| 1997 | 4.26 Billion EUR | -30.78% |
| 1996 | 6.15 Billion EUR | 15.15% |
| 1995 | 5.34 Billion EUR | -25.5% |
| 1994 | 7.17 Billion EUR | -4.62% |
| 1993 | 7.52 Billion EUR | -36.41% |
| 1992 | 11.83 Billion EUR | 91.94% |
| 1991 | 6.16 Billion EUR | -6.08% |
| 1990 | 6.56 Billion EUR | -39.58% |
| 1989 | 10.86 Billion EUR | -6.46% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 8.26 Billion EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q3 | - EUR | -100.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q4 | 7.61 Billion EUR | 0.0% |
| 2023 Q2 | 8.21 Billion EUR | -49.75% |
| 2023 Q1 | 16.35 Billion USD | 99.37% |
| 2023 FY | 7.61 Billion EUR | -7.17% |
| 2022 Q2 | 8 Billion EUR | 0.0% |
| 2022 Q4 | 8.2 Billion EUR | 0.0% |
| 2022 FY | 8.2 Billion EUR | 17.51% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2021 Q2 | 7.83 Billion EUR | 0.0% |
| 2021 Q4 | 6.97 Billion EUR | 0.0% |
| 2021 FY | 6.97 Billion EUR | 0.65% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2020 Q2 | 7.29 Billion EUR | 0.0% |
| 2020 Q4 | 6.93 Billion EUR | 0.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 FY | 6.93 Billion EUR | 27.3% |
| 2020 Q3 | - EUR | -100.0% |
| 2019 Q4 | 5.44 Billion EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | 5.81 Billion EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 FY | 5.44 Billion EUR | 12.98% |
| 2018 Q2 | 4.92 Billion EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q4 | 4.82 Billion EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 FY | 4.82 Billion EUR | 2.23% |
| 2017 Q4 | 4.71 Billion EUR | -0.72% |
| 2017 FY | 4.71 Billion EUR | -15.88% |
| 2017 Q1 | 5.34 Billion EUR | -4.67% |
| 2017 Q2 | 2.89 Billion EUR | -45.81% |
| 2017 Q3 | 4.75 Billion EUR | 64.02% |
| 2016 Q3 | 5.76 Billion EUR | -0.69% |
| 2016 Q1 | 5.68 Billion EUR | -1.23% |
| 2016 Q2 | 5.8 Billion EUR | 2.09% |
| 2016 Q4 | 5.6 Billion EUR | -2.81% |
| 2016 FY | 5.6 Billion EUR | -2.67% |
| 2015 Q3 | 5.54 Billion EUR | -2.34% |
| 2015 Q1 | 5.78 Billion EUR | 40.96% |
| 2015 Q4 | 5.76 Billion EUR | 3.84% |
| 2015 FY | 5.76 Billion EUR | 40.35% |
| 2015 Q2 | 5.68 Billion EUR | -1.82% |
| 2014 Q1 | 3.71 Billion EUR | -4.72% |
| 2014 Q4 | 4.1 Billion EUR | -4.76% |
| 2014 Q3 | 4.3 Billion EUR | 14.36% |
| 2014 Q2 | 3.76 Billion EUR | 1.37% |
| 2014 FY | 4.1 Billion EUR | 5.2% |
| 2013 Q1 | 4.6 Billion EUR | 1.5% |
| 2013 FY | 3.9 Billion EUR | -13.96% |
| 2013 Q2 | 4.41 Billion EUR | -4.15% |
| 2013 Q4 | 3.9 Billion EUR | -4.06% |
| 2013 Q3 | 4.06 Billion EUR | -7.82% |
| 2012 Q1 | 5.01 Billion EUR | 29.84% |
| 2012 Q2 | 4.9 Billion EUR | -2.23% |
| 2012 FY | 4.53 Billion EUR | 17.46% |
| 2012 Q4 | 4.53 Billion EUR | -3.45% |
| 2012 Q3 | 4.69 Billion EUR | -4.16% |
| 2011 Q1 | 4.33 Billion EUR | -6.93% |
| 2011 FY | 3.86 Billion EUR | -17.13% |
| 2011 Q3 | 3.52 Billion EUR | 3.28% |
| 2011 Q4 | 3.86 Billion EUR | 9.41% |
| 2011 Q2 | 3.41 Billion EUR | -21.2% |
| 2010 Q2 | 4.79 Billion EUR | 7.55% |
| 2010 FY | 4.65 Billion EUR | 9.16% |
| 2010 Q1 | 4.46 Billion EUR | 4.57% |
| 2010 Q4 | 4.65 Billion EUR | 4.32% |
| 2010 Q3 | 4.46 Billion EUR | -6.96% |
| 2009 Q3 | 4.35 Billion EUR | -1.67% |
| 2009 Q4 | 4.26 Billion EUR | -2.02% |
| 2009 Q2 | 4.42 Billion EUR | -2.32% |
| 2009 Q1 | 4.53 Billion EUR | 9.04% |
| 2009 FY | 4.26 Billion EUR | 1.89% |
| 2008 Q2 | 3.91 Billion EUR | -27.52% |
| 2008 FY | 4.18 Billion EUR | 17.56% |
| 2008 Q1 | 5.4 Billion EUR | 51.63% |
| 2008 Q3 | 3.95 Billion EUR | 0.98% |
| 2008 Q4 | 4.15 Billion EUR | 5.17% |
| 2007 Q4 | 3.56 Billion EUR | -42.38% |
| 2007 Q3 | 6.18 Billion EUR | 62.4% |
| 2007 FY | 3.56 Billion EUR | -7.92% |
| 2007 Q1 | 3.93 Billion EUR | 1.64% |
| 2007 Q2 | 3.8 Billion EUR | -3.19% |
| 2006 Q4 | 3.86 Billion EUR | -0.93% |
| 2006 Q3 | 3.9 Billion EUR | -14.17% |
| 2006 Q1 | 4.69 Billion EUR | 4.61% |
| 2006 FY | 3.86 Billion EUR | -13.71% |
| 2006 Q2 | 4.55 Billion EUR | -2.99% |
| 2005 Q1 | 4.49 Billion EUR | -0.33% |
| 2005 FY | 4.48 Billion EUR | -0.6% |
| 2005 Q4 | 4.48 Billion EUR | 3.33% |
| 2005 Q3 | 4.33 Billion EUR | -2.65% |
| 2005 Q2 | 4.45 Billion EUR | -0.85% |
| 2004 Q4 | 4.51 Billion EUR | -6.48% |
| 2004 FY | 4.51 Billion EUR | -23.11% |
| 2004 Q1 | 6.13 Billion EUR | 4.55% |
| 2004 Q2 | 6.13 Billion EUR | 0.13% |
| 2004 Q3 | 4.82 Billion EUR | -21.45% |
| 2003 Q4 | 5.86 Billion EUR | -4.13% |
| 2003 FY | 5.86 Billion EUR | -17.57% |
| 2003 Q3 | 6.11 Billion EUR | -11.6% |
| 2003 Q2 | 6.92 Billion EUR | -2.83% |
| 2003 Q1 | 7.12 Billion EUR | 0.09% |
| 2002 FY | 7.11 Billion EUR | -9.69% |
| 2002 Q1 | 7.98 Billion EUR | 1.4% |
| 2002 Q2 | 11.29 Billion EUR | 41.37% |
| 2002 Q3 | 11.24 Billion EUR | -0.41% |
| 2002 Q4 | 7.11 Billion EUR | -36.74% |
| 2001 FY | 7.87 Billion EUR | 95.11% |
| 2001 Q2 | 6.21 Billion EUR | 15.17% |
| 2001 Q1 | 5.39 Billion EUR | 33.64% |
| 2001 Q3 | 8.25 Billion EUR | 32.82% |
| 2001 Q4 | 7.87 Billion EUR | -4.56% |
| 2000 Q1 | 3.28 Billion EUR | -1.04% |
| 2000 FY | 4.03 Billion EUR | 21.52% |
| 2000 Q2 | 3.43 Billion EUR | 4.45% |
| 2000 Q3 | 3.5 Billion EUR | 2.18% |
| 2000 Q4 | 4.03 Billion EUR | 15.06% |
| 1999 FY | 3.32 Billion EUR | -6.83% |
| 1999 Q2 | 3.48 Billion EUR | 0.6% |
| 1999 Q1 | 3.46 Billion EUR | -2.98% |
| 1999 Q3 | 3.36 Billion EUR | -3.22% |
| 1999 Q4 | 3.32 Billion EUR | -1.35% |
| 1998 Q1 | 3.18 Billion EUR | -25.23% |
| 1998 FY | 3.56 Billion EUR | -16.29% |
| 1998 Q4 | 3.56 Billion EUR | 25.47% |
| 1998 Q3 | 2.84 Billion EUR | -4.29% |
| 1998 Q2 | 2.96 Billion EUR | -6.77% |
| 1997 Q1 | 5.9 Billion EUR | -4.05% |
| 1997 FY | 4.26 Billion EUR | -30.78% |
| 1997 Q4 | 4.26 Billion EUR | -23.33% |
| 1997 Q3 | 5.55 Billion EUR | -9.9% |
| 1997 Q2 | 6.16 Billion EUR | 4.43% |
| 1996 Q4 | 6.15 Billion EUR | 0.0% |
| 1996 FY | 6.15 Billion EUR | 15.15% |
| 1995 FY | 5.34 Billion EUR | -25.5% |
| 1995 Q4 | 5.34 Billion EUR | 0.0% |
| 1994 Q4 | 7.17 Billion EUR | 0.0% |
| 1994 FY | 7.17 Billion EUR | -4.62% |
| 1993 Q4 | 7.52 Billion EUR | 0.0% |
| 1993 FY | 7.52 Billion EUR | -36.41% |
| 1992 Q4 | 11.83 Billion EUR | 0.0% |
| 1992 FY | 11.83 Billion EUR | 91.94% |
| 1991 FY | 6.16 Billion EUR | -6.08% |
| 1991 Q4 | 6.16 Billion EUR | 0.0% |
| 1990 Q4 | 6.56 Billion EUR | 0.0% |
| 1990 FY | 6.56 Billion EUR | -39.58% |
| 1989 Q4 | 10.86 Billion EUR | 0.0% |
| 1989 FY | 10.86 Billion EUR | -6.46% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Abbott Laboratories | 15.87 Billion USD | 52.038% |
| Allurion Technologies Inc. | 41.85 Million USD | -18088.117% |
| Artivion, Inc. | 359.34 Million USD | -2018.6% |
| Avanos Medical, Inc. | 209.1 Million USD | -3540.842% |
| Butterfly Network, Inc. | 25.02 Million USD | -30319.147% |
| Butterfly Network, Inc. | 25.02 Million USD | -30319.147% |
| Bio-Rad Laboratories, Inc. | 1.4 Billion USD | -441.506% |
| Boston Scientific Corporation | 9.49 Billion USD | 19.796% |
| Perspective Therapeutics, Inc. | - USD | -Infinity% |
| CONMED Corporation | 991.25 Million USD | -668.017% |
| Edwards Lifesciences Corporation | 694.9 Million USD | -995.553% |
| Paragon 28, Inc. | 112.03 Million USD | -6695.501% |
| Glaukos Corporation | 383.73 Million USD | -1883.906% |
| Globus Medical, Inc. | 520.4 Million USD | -1362.902% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -30540.747% |
| Integer Holdings Corporation | 1.04 Billion USD | -631.347% |
| Medtronic plc | 26.04 Billion USD | 70.772% |
| Nevro Corp. | 221.82 Million USD | -3331.954% |
| Owlet, Inc. | 15.21 Million USD | -49932.86% |
| Penumbra, Inc. | 234.34 Million USD | -3148.657% |
| Vicarious Surgical Inc. | 14.83 Million USD | -51228.209% |
| Smith & Nephew plc | 3.08 Billion USD | -146.855% |
| Sonendo, Inc. | 40.35 Million USD | -18766.943% |
| STERIS plc | 3.38 Billion USD | -125.026% |
| Stryker Corporation | 12.99 Billion USD | 41.416% |
| Vapotherm, Inc. | 112.39 Million USD | -6673.614% |
| Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | -26.985% |